nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—ADRA2B—hypertension	0.0805	0.234	CbGaD
Lisuride—HTR2B—hypertension	0.0665	0.193	CbGaD
Lisuride—HTR1B—hypertension	0.0398	0.116	CbGaD
Lisuride—DRD3—hypertension	0.0387	0.113	CbGaD
Lisuride—ADRA2A—hypertension	0.0353	0.103	CbGaD
Lisuride—ADRB1—hypertension	0.0352	0.103	CbGaD
Lisuride—DRD2—hypertension	0.0268	0.0779	CbGaD
Lisuride—HTR2A—hypertension	0.0207	0.0602	CbGaD
Lisuride—DRD5—Fenoldopam—hypertension	0.0156	0.0368	CbGbCtD
Lisuride—ADRB1—Esmolol—hypertension	0.0126	0.0296	CbGbCtD
Lisuride—HTR1B—Pindolol—hypertension	0.0103	0.0244	CbGbCtD
Lisuride—ADRA2C—Guanabenz—hypertension	0.0101	0.0238	CbGbCtD
Lisuride—ADRA1D—Terazosin—hypertension	0.00972	0.0229	CbGbCtD
Lisuride—ADRA2B—Guanabenz—hypertension	0.00958	0.0226	CbGbCtD
Lisuride—ADRB1—Nadolol—hypertension	0.00952	0.0224	CbGbCtD
Lisuride—ADRB1—Labetalol—hypertension	0.00952	0.0224	CbGbCtD
Lisuride—ADRB1—Nebivolol—hypertension	0.00952	0.0224	CbGbCtD
Lisuride—ADRA2B—Guanfacine—hypertension	0.00891	0.021	CbGbCtD
Lisuride—ADRA1D—Fenoldopam—hypertension	0.00879	0.0207	CbGbCtD
Lisuride—ADRB1—Acebutolol—hypertension	0.0087	0.0205	CbGbCtD
Lisuride—HTR1B—Penbutolol—hypertension	0.00843	0.0199	CbGbCtD
Lisuride—ADRA1D—Doxazosin—hypertension	0.00812	0.0191	CbGbCtD
Lisuride—ADRB1—Pindolol—hypertension	0.00809	0.0191	CbGbCtD
Lisuride—ADRB1—Metoprolol—hypertension	0.00809	0.0191	CbGbCtD
Lisuride—ADRA2C—Fenoldopam—hypertension	0.00799	0.0188	CbGbCtD
Lisuride—DRD1—Fenoldopam—hypertension	0.00799	0.0188	CbGbCtD
Lisuride—HTR1A—Nebivolol—hypertension	0.00762	0.0179	CbGbCtD
Lisuride—ADRA2B—Fenoldopam—hypertension	0.00758	0.0178	CbGbCtD
Lisuride—ADRA2A—Methyldopa—hypertension	0.00729	0.0172	CbGbCtD
Lisuride—ADRB1—Betaxolol—hypertension	0.00721	0.017	CbGbCtD
Lisuride—ADRA1B—Terazosin—hypertension	0.00708	0.0167	CbGbCtD
Lisuride—HTR1D—Prazosin—hypertension	0.00695	0.0164	CbGbCtD
Lisuride—ADRA1D—Prazosin—hypertension	0.00667	0.0157	CbGbCtD
Lisuride—ADRA2A—Guanabenz—hypertension	0.00666	0.0157	CbGbCtD
Lisuride—ADRB1—Penbutolol—hypertension	0.0066	0.0155	CbGbCtD
Lisuride—HTR1A—Pindolol—hypertension	0.00648	0.0153	CbGbCtD
Lisuride—ADRA1B—Fenoldopam—hypertension	0.0064	0.0151	CbGbCtD
Lisuride—ADRA2A—Guanfacine—hypertension	0.0062	0.0146	CbGbCtD
Lisuride—ADRA1B—Doxazosin—hypertension	0.00591	0.0139	CbGbCtD
Lisuride—ADRA1D—Nicardipine—hypertension	0.00575	0.0136	CbGbCtD
Lisuride—ADRA1D—Carvedilol—hypertension	0.00575	0.0136	CbGbCtD
Lisuride—ADRA2B—Prazosin—hypertension	0.00574	0.0135	CbGbCtD
Lisuride—HTR1B—Propranolol—hypertension	0.00529	0.0125	CbGbCtD
Lisuride—HTR1A—Penbutolol—hypertension	0.00528	0.0124	CbGbCtD
Lisuride—ADRA2A—Fenoldopam—hypertension	0.00527	0.0124	CbGbCtD
Lisuride—ADRA2C—Carvedilol—hypertension	0.00522	0.0123	CbGbCtD
Lisuride—ADRA1D—Clonidine—hypertension	0.00505	0.0119	CbGbCtD
Lisuride—ADRA2B—Carvedilol—hypertension	0.00496	0.0117	CbGbCtD
Lisuride—ADRA2A—Doxazosin—hypertension	0.00486	0.0115	CbGbCtD
Lisuride—DRD2—Fenoldopam—hypertension	0.00485	0.0114	CbGbCtD
Lisuride—ADRA1B—Prazosin—hypertension	0.00485	0.0114	CbGbCtD
Lisuride—ADRA1B—vas deferens—hypertension	0.00483	0.168	CbGeAlD
Lisuride—ADRB1—Timolol—hypertension	0.00465	0.011	CbGbCtD
Lisuride—ADRA2C—Clonidine—hypertension	0.00459	0.0108	CbGbCtD
Lisuride—ADRB1—Carvedilol—hypertension	0.0045	0.0106	CbGbCtD
Lisuride—ADRA2B—Clonidine—hypertension	0.00435	0.0103	CbGbCtD
Lisuride—ADRA1B—Nicardipine—hypertension	0.00419	0.00987	CbGbCtD
Lisuride—ADRA1B—Carvedilol—hypertension	0.00419	0.00987	CbGbCtD
Lisuride—HTR1A—Prazosin—hypertension	0.00417	0.00983	CbGbCtD
Lisuride—ADRB1—Propranolol—hypertension	0.00414	0.00976	CbGbCtD
Lisuride—ADRA2A—Prazosin—hypertension	0.00399	0.00941	CbGbCtD
Lisuride—ADRA1B—Clonidine—hypertension	0.00368	0.00866	CbGbCtD
Lisuride—ADRA2A—Carvedilol—hypertension	0.00345	0.00812	CbGbCtD
Lisuride—HTR1A—Propranolol—hypertension	0.00332	0.00781	CbGbCtD
Lisuride—ADRA2A—Clonidine—hypertension	0.00303	0.00713	CbGbCtD
Lisuride—CYP2D6—Nebivolol—hypertension	0.00242	0.00571	CbGbCtD
Lisuride—CYP2D6—Labetalol—hypertension	0.00242	0.00571	CbGbCtD
Lisuride—CYP2D6—Acebutolol—hypertension	0.00222	0.00522	CbGbCtD
Lisuride—CYP2D6—Pindolol—hypertension	0.00206	0.00486	CbGbCtD
Lisuride—CYP2D6—Metoprolol—hypertension	0.00206	0.00486	CbGbCtD
Lisuride—CYP3A4—Guanethidine—hypertension	0.00203	0.00479	CbGbCtD
Lisuride—CYP2D6—Betaxolol—hypertension	0.00184	0.00433	CbGbCtD
Lisuride—CYP2D6—Doxazosin—hypertension	0.00162	0.00381	CbGbCtD
Lisuride—CYP2D6—Diltiazem—hypertension	0.00156	0.00368	CbGbCtD
Lisuride—CYP3A4—Hydralazine—hypertension	0.00154	0.00363	CbGbCtD
Lisuride—CYP2D6—Bepridil—hypertension	0.00139	0.00328	CbGbCtD
Lisuride—CYP3A4—Guanfacine—hypertension	0.00131	0.00309	CbGbCtD
Lisuride—CYP2D6—Irbesartan—hypertension	0.00127	0.003	CbGbCtD
Lisuride—HTR2A—arteriole—hypertension	0.00125	0.0436	CbGeAlD
Lisuride—CYP2D6—Amlodipine—hypertension	0.00125	0.00294	CbGbCtD
Lisuride—CYP2D6—Felodipine—hypertension	0.0012	0.00284	CbGbCtD
Lisuride—CYP2D6—Timolol—hypertension	0.00118	0.00279	CbGbCtD
Lisuride—CYP3A4—Isradipine—hypertension	0.00117	0.00275	CbGbCtD
Lisuride—CYP2D6—Nifedipine—hypertension	0.00116	0.00274	CbGbCtD
Lisuride—CYP2D6—Nicardipine—hypertension	0.00115	0.0027	CbGbCtD
Lisuride—CYP2D6—Carvedilol—hypertension	0.00115	0.0027	CbGbCtD
Lisuride—CYP2D6—Propranolol—hypertension	0.00105	0.00249	CbGbCtD
Lisuride—CYP2D6—Captopril—hypertension	0.00104	0.00245	CbGbCtD
Lisuride—CYP3A4—Nisoldipine—hypertension	0.00103	0.00242	CbGbCtD
Lisuride—CYP3A4—Indapamide—hypertension	0.00103	0.00242	CbGbCtD
Lisuride—HTR2A—locus ceruleus—hypertension	0.00101	0.0351	CbGeAlD
Lisuride—CYP2D6—Clonidine—hypertension	0.00101	0.00237	CbGbCtD
Lisuride—CYP3A4—Diltiazem—hypertension	0.000993	0.00234	CbGbCtD
Lisuride—CYP3A4—Eplerenone—hypertension	0.000993	0.00234	CbGbCtD
Lisuride—CYP2D6—Atorvastatin—hypertension	0.000897	0.00211	CbGbCtD
Lisuride—CYP3A4—Enalapril—hypertension	0.000885	0.00209	CbGbCtD
Lisuride—HTR2A—pulmonary artery—hypertension	0.000818	0.0285	CbGeAlD
Lisuride—CYP3A4—Irbesartan—hypertension	0.00081	0.00191	CbGbCtD
Lisuride—HTR2A—sympathetic nervous system—hypertension	0.000796	0.0278	CbGeAlD
Lisuride—CYP3A4—Amlodipine—hypertension	0.000794	0.00187	CbGbCtD
Lisuride—HTR2A—vagus nerve—hypertension	0.000771	0.0269	CbGeAlD
Lisuride—CYP3A4—Felodipine—hypertension	0.000766	0.0018	CbGbCtD
Lisuride—HTR2A—vein—hypertension	0.000745	0.026	CbGeAlD
Lisuride—CYP3A4—Nifedipine—hypertension	0.00074	0.00174	CbGbCtD
Lisuride—CYP3A4—Carvedilol—hypertension	0.000729	0.00172	CbGbCtD
Lisuride—CYP3A4—Nicardipine—hypertension	0.000729	0.00172	CbGbCtD
Lisuride—CYP2D6—Verapamil—hypertension	0.000724	0.00171	CbGbCtD
Lisuride—CYP3A4—Propranolol—hypertension	0.000671	0.00158	CbGbCtD
Lisuride—CYP3A4—Clonidine—hypertension	0.00064	0.00151	CbGbCtD
Lisuride—HTR1B—artery—hypertension	0.000631	0.022	CbGeAlD
Lisuride—HTR1D—artery—hypertension	0.000611	0.0213	CbGeAlD
Lisuride—CYP3A4—Atorvastatin—hypertension	0.00057	0.00134	CbGbCtD
Lisuride—DRD4—heart—hypertension	0.00057	0.0199	CbGeAlD
Lisuride—HTR2A—autonomic nervous system—hypertension	0.000535	0.0187	CbGeAlD
Lisuride—CYP3A4—Losartan—hypertension	0.000522	0.00123	CbGbCtD
Lisuride—HTR2A—hindlimb—hypertension	0.000495	0.0173	CbGeAlD
Lisuride—HTR1B—blood vessel—hypertension	0.000491	0.0171	CbGeAlD
Lisuride—HTR1D—blood vessel—hypertension	0.000476	0.0166	CbGeAlD
Lisuride—CYP3A4—Verapamil—hypertension	0.00046	0.00108	CbGbCtD
Lisuride—HTR2A—urine—hypertension	0.000436	0.0152	CbGeAlD
Lisuride—CYP3A4—urine—hypertension	0.000404	0.0141	CbGeAlD
Lisuride—CYP2D6—urine—hypertension	0.000397	0.0139	CbGeAlD
Lisuride—ADRB1—cardiac ventricle—hypertension	0.000333	0.0116	CbGeAlD
Lisuride—DRD1—brainstem—hypertension	0.000332	0.0116	CbGeAlD
Lisuride—ADRB1—myocardium—hypertension	0.000313	0.0109	CbGeAlD
Lisuride—HTR2A—artery—hypertension	0.000303	0.0106	CbGeAlD
Lisuride—ADRA1B—kidney—hypertension	0.000284	0.00991	CbGeAlD
Lisuride—HTR1B—brainstem—hypertension	0.000269	0.00937	CbGeAlD
Lisuride—HTR1D—brainstem—hypertension	0.00026	0.00907	CbGeAlD
Lisuride—HTR2C—brainstem—hypertension	0.000258	0.00898	CbGeAlD
Lisuride—HTR2A—endothelium—hypertension	0.000256	0.00894	CbGeAlD
Lisuride—ADRA2C—cardiac ventricle—hypertension	0.000251	0.00875	CbGeAlD
Lisuride—DRD5—endocrine gland—hypertension	0.000243	0.00847	CbGeAlD
Lisuride—HTR2A—blood vessel—hypertension	0.000236	0.00824	CbGeAlD
Lisuride—ADRA2C—myocardium—hypertension	0.000236	0.00823	CbGeAlD
Lisuride—DRD3—central nervous system—hypertension	0.000234	0.00815	CbGeAlD
Lisuride—Cabergoline—ADRA2B—hypertension	0.000221	0.0631	CrCbGaD
Lisuride—HTR1B—cardiovascular system—hypertension	0.000219	0.00765	CbGeAlD
Lisuride—DRD5—central nervous system—hypertension	0.000219	0.00764	CbGeAlD
Lisuride—ADRB1—heart—hypertension	0.000219	0.00762	CbGeAlD
Lisuride—HTR1A—brainstem—hypertension	0.000217	0.00756	CbGeAlD
Lisuride—HTR2B—adrenal cortex—hypertension	0.000216	0.00755	CbGeAlD
Lisuride—HTR1D—cardiovascular system—hypertension	0.000212	0.0074	CbGeAlD
Lisuride—HTR2B—heart—hypertension	0.000209	0.0073	CbGeAlD
Lisuride—HTR1D—kidney—hypertension	0.000208	0.00724	CbGeAlD
Lisuride—HTR2B—smooth muscle tissue—hypertension	0.000208	0.00724	CbGeAlD
Lisuride—ADRB1—cardiovascular system—hypertension	0.000206	0.00719	CbGeAlD
Lisuride—HTR2B—decidua—hypertension	0.000203	0.0071	CbGeAlD
Lisuride—HTR2B—cardiovascular system—hypertension	0.000197	0.00689	CbGeAlD
Lisuride—DRD2—brainstem—hypertension	0.000196	0.00683	CbGeAlD
Lisuride—ADRA1D—endocrine gland—hypertension	0.000195	0.00679	CbGeAlD
Lisuride—HTR2B—cortex of kidney—hypertension	0.000188	0.00656	CbGeAlD
Lisuride—ADRB1—cardiac atrium—hypertension	0.000187	0.00652	CbGeAlD
Lisuride—Methylergometrine—HTR2B—hypertension	0.000182	0.0521	CrCbGaD
Lisuride—Cabergoline—HTR2B—hypertension	0.000182	0.0521	CrCbGaD
Lisuride—HTR2C—medulla oblongata—hypertension	0.00018	0.00626	CbGeAlD
Lisuride—ADRA1B—central nervous system—hypertension	0.000179	0.00626	CbGeAlD
Lisuride—HTR1A—cardiovascular system—hypertension	0.000177	0.00617	CbGeAlD
Lisuride—ADRA1D—central nervous system—hypertension	0.000175	0.00612	CbGeAlD
Lisuride—ADRA2C—nephron tubule—hypertension	0.000173	0.00604	CbGeAlD
Lisuride—Pergolide—ADRA2B—hypertension	0.00017	0.0488	CrCbGaD
Lisuride—ADRA2C—adrenal cortex—hypertension	0.00017	0.00594	CbGeAlD
Lisuride—DRD1—central nervous system—hypertension	0.000167	0.00583	CbGeAlD
Lisuride—ADRA2C—heart—hypertension	0.000165	0.00575	CbGeAlD
Lisuride—ADRA2C—decidua—hypertension	0.00016	0.00559	CbGeAlD
Lisuride—HTR2B—adrenal gland—hypertension	0.000156	0.00545	CbGeAlD
Lisuride—Ergonovine—ADRA1A—hypertension	0.000156	0.0447	CrCbGaD
Lisuride—ADRA2C—kidney—hypertension	0.000152	0.0053	CbGeAlD
Lisuride—Methysergide—HTR2B—hypertension	0.000152	0.0434	CrCbGaD
Lisuride—HTR1B—endocrine gland—hypertension	0.00015	0.00525	CbGeAlD
Lisuride—ADRA2C—cortex of kidney—hypertension	0.000148	0.00517	CbGeAlD
Lisuride—Ergotamine—ADRA2B—hypertension	0.000142	0.0407	CrCbGaD
Lisuride—ADRB1—endocrine gland—hypertension	0.000141	0.00494	CbGeAlD
Lisuride—ADRA2C—cardiac atrium—hypertension	0.000141	0.00491	CbGeAlD
Lisuride—Pergolide—HTR2B—hypertension	0.000141	0.0402	CrCbGaD
Lisuride—HTR1A—adrenal gland—hypertension	0.00014	0.00488	CbGeAlD
Lisuride—Cabergoline—ADRA1A—hypertension	0.000136	0.039	CrCbGaD
Lisuride—HTR1B—central nervous system—hypertension	0.000135	0.00473	CbGeAlD
Lisuride—ADRA2C—medulla oblongata—hypertension	0.000133	0.00463	CbGeAlD
Lisuride—ADRA2A—heart—hypertension	0.000131	0.00458	CbGeAlD
Lisuride—HTR1D—central nervous system—hypertension	0.000131	0.00458	CbGeAlD
Lisuride—HTR2C—central nervous system—hypertension	0.00013	0.00453	CbGeAlD
Lisuride—HTR2A—brainstem—hypertension	0.000129	0.00451	CbGeAlD
Lisuride—ADRA2A—decidua—hypertension	0.000128	0.00446	CbGeAlD
Lisuride—ADRB1—central nervous system—hypertension	0.000127	0.00445	CbGeAlD
Lisuride—Ergotamine—SLC6A2—hypertension	0.000125	0.0357	CrCbGaD
Lisuride—ADRA2C—adrenal gland—hypertension	0.000123	0.00429	CbGeAlD
Lisuride—HTR2B—central nervous system—hypertension	0.000122	0.00426	CbGeAlD
Lisuride—HTR1A—endocrine gland—hypertension	0.000121	0.00423	CbGeAlD
Lisuride—ADRA2A—cortex of kidney—hypertension	0.000118	0.00412	CbGeAlD
Lisuride—CYP2D6—brainstem—hypertension	0.000118	0.00411	CbGeAlD
Lisuride—Ergotamine—HTR2B—hypertension	0.000117	0.0335	CrCbGaD
Lisuride—Cabergoline—HTR7—hypertension	0.000113	0.0322	CrCbGaD
Lisuride—ADRA2A—cardiac atrium—hypertension	0.000112	0.00392	CbGeAlD
Lisuride—HTR2A—heart—hypertension	0.000112	0.0039	CbGeAlD
Lisuride—HTR2A—smooth muscle tissue—hypertension	0.000111	0.00387	CbGeAlD
Lisuride—DRD2—endocrine gland—hypertension	0.00011	0.00382	CbGeAlD
Lisuride—HTR1A—central nervous system—hypertension	0.000109	0.00381	CbGeAlD
Lisuride—Cabergoline—HTR1B—hypertension	0.000109	0.0312	CrCbGaD
Lisuride—ADRA2A—medulla oblongata—hypertension	0.000106	0.0037	CbGeAlD
Lisuride—Cabergoline—DRD3—hypertension	0.000106	0.0303	CrCbGaD
Lisuride—Pergolide—ADRA1A—hypertension	0.000105	0.0302	CrCbGaD
Lisuride—HTR2A—cardiovascular system—hypertension	0.000105	0.00368	CbGeAlD
Lisuride—HTR2A—kidney—hypertension	0.000103	0.0036	CbGeAlD
Lisuride—DRD2—central nervous system—hypertension	9.88e-05	0.00345	CbGeAlD
Lisuride—ADRA2A—adrenal gland—hypertension	9.81e-05	0.00342	CbGeAlD
Lisuride—Cabergoline—ADRA2A—hypertension	9.66e-05	0.0276	CrCbGaD
Lisuride—Cabergoline—ADRB1—hypertension	9.65e-05	0.0276	CrCbGaD
Lisuride—ADRA2C—central nervous system—hypertension	9.6e-05	0.00335	CbGeAlD
Lisuride—CYP3A4—kidney—hypertension	9.55e-05	0.00333	CbGeAlD
Lisuride—Methysergide—HTR7—hypertension	9.4e-05	0.0269	CrCbGaD
Lisuride—CYP2D6—kidney—hypertension	9.4e-05	0.00328	CbGeAlD
Lisuride—Methysergide—HTR1B—hypertension	9.11e-05	0.026	CrCbGaD
Lisuride—HTR2A—medulla oblongata—hypertension	9.01e-05	0.00314	CbGeAlD
Lisuride—Ergotamine—ADRA1A—hypertension	8.79e-05	0.0252	CrCbGaD
Lisuride—ADRA2A—endocrine gland—hypertension	8.5e-05	0.00297	CbGeAlD
Lisuride—Pergolide—HTR1B—hypertension	8.43e-05	0.0241	CrCbGaD
Lisuride—HTR2A—adrenal gland—hypertension	8.34e-05	0.00291	CbGeAlD
Lisuride—Pergolide—DRD3—hypertension	8.19e-05	0.0234	CrCbGaD
Lisuride—Cabergoline—ADRB2—hypertension	8.12e-05	0.0232	CrCbGaD
Lisuride—ADRA2A—central nervous system—hypertension	7.66e-05	0.00267	CbGeAlD
Lisuride—Pergolide—ADRA2A—hypertension	7.47e-05	0.0214	CrCbGaD
Lisuride—Cabergoline—DRD2—hypertension	7.33e-05	0.021	CrCbGaD
Lisuride—HTR2A—endocrine gland—hypertension	7.23e-05	0.00252	CbGeAlD
Lisuride—Ergotamine—HTR1B—hypertension	7.03e-05	0.0201	CrCbGaD
Lisuride—CYP3A4—endocrine gland—hypertension	6.69e-05	0.00234	CbGeAlD
Lisuride—CYP2D6—endocrine gland—hypertension	6.59e-05	0.0023	CbGeAlD
Lisuride—HTR2A—central nervous system—hypertension	6.52e-05	0.00227	CbGeAlD
Lisuride—Ergotamine—ADRA2A—hypertension	6.23e-05	0.0178	CrCbGaD
Lisuride—CYP3A4—central nervous system—hypertension	6.03e-05	0.0021	CbGeAlD
Lisuride—CYP2D6—central nervous system—hypertension	5.94e-05	0.00207	CbGeAlD
Lisuride—Pergolide—DRD2—hypertension	5.66e-05	0.0162	CrCbGaD
Lisuride—Cabergoline—HTR2A—hypertension	5.66e-05	0.0162	CrCbGaD
Lisuride—Methylergometrine—HTR2A—hypertension	5.66e-05	0.0162	CrCbGaD
Lisuride—Methysergide—HTR2A—hypertension	4.73e-05	0.0135	CrCbGaD
Lisuride—Ergotamine—DRD2—hypertension	4.72e-05	0.0135	CrCbGaD
Lisuride—Pergolide—HTR2A—hypertension	4.38e-05	0.0125	CrCbGaD
Lisuride—Hyperhidrosis—Hydrochlorothiazide—hypertension	3.86e-05	0.000362	CcSEcCtD
Lisuride—Somnolence—Enalapril—hypertension	3.86e-05	0.000361	CcSEcCtD
Lisuride—Gastrointestinal disorder—Clonidine—hypertension	3.86e-05	0.000361	CcSEcCtD
Lisuride—Nervous system disorder—Furosemide—hypertension	3.85e-05	0.000361	CcSEcCtD
Lisuride—Anorexia—Perindopril—hypertension	3.85e-05	0.000361	CcSEcCtD
Lisuride—Fatigue—Clonidine—hypertension	3.85e-05	0.000361	CcSEcCtD
Lisuride—Feeling abnormal—Olmesartan—hypertension	3.84e-05	0.00036	CcSEcCtD
Lisuride—Anorexia—Irbesartan—hypertension	3.84e-05	0.00036	CcSEcCtD
Lisuride—Confusional state—Losartan—hypertension	3.82e-05	0.000358	CcSEcCtD
Lisuride—Constipation—Clonidine—hypertension	3.82e-05	0.000358	CcSEcCtD
Lisuride—Dyspnoea—Telmisartan—hypertension	3.82e-05	0.000358	CcSEcCtD
Lisuride—Nervous system disorder—Betaxolol—hypertension	3.81e-05	0.000357	CcSEcCtD
Lisuride—Anorexia—Hydrochlorothiazide—hypertension	3.81e-05	0.000357	CcSEcCtD
Lisuride—Somnolence—Telmisartan—hypertension	3.81e-05	0.000357	CcSEcCtD
Lisuride—Asthenia—Indapamide—hypertension	3.8e-05	0.000356	CcSEcCtD
Lisuride—Asthenia—Diltiazem—hypertension	3.8e-05	0.000356	CcSEcCtD
Lisuride—Hyperhidrosis—Furosemide—hypertension	3.8e-05	0.000356	CcSEcCtD
Lisuride—Tachycardia—Betaxolol—hypertension	3.8e-05	0.000356	CcSEcCtD
Lisuride—Vomiting—Metoprolol—hypertension	3.79e-05	0.000355	CcSEcCtD
Lisuride—Vomiting—Guanabenz—hypertension	3.79e-05	0.000355	CcSEcCtD
Lisuride—Decreased appetite—Trandolapril—hypertension	3.79e-05	0.000355	CcSEcCtD
Lisuride—Decreased appetite—Enalapril—hypertension	3.77e-05	0.000353	CcSEcCtD
Lisuride—Infection—Losartan—hypertension	3.77e-05	0.000353	CcSEcCtD
Lisuride—Insomnia—Captopril—hypertension	3.76e-05	0.000353	CcSEcCtD
Lisuride—Angiopathy—Lisinopril—hypertension	3.76e-05	0.000353	CcSEcCtD
Lisuride—Asthenia—Carvedilol—hypertension	3.76e-05	0.000353	CcSEcCtD
Lisuride—Gastrointestinal disorder—Trandolapril—hypertension	3.76e-05	0.000352	CcSEcCtD
Lisuride—Hyperhidrosis—Betaxolol—hypertension	3.76e-05	0.000352	CcSEcCtD
Lisuride—Fatigue—Trandolapril—hypertension	3.76e-05	0.000352	CcSEcCtD
Lisuride—Anorexia—Furosemide—hypertension	3.74e-05	0.000351	CcSEcCtD
Lisuride—Fatigue—Enalapril—hypertension	3.74e-05	0.000351	CcSEcCtD
Lisuride—Mediastinal disorder—Lisinopril—hypertension	3.74e-05	0.00035	CcSEcCtD
Lisuride—Headache—Metoprolol—hypertension	3.73e-05	0.00035	CcSEcCtD
Lisuride—Headache—Guanabenz—hypertension	3.73e-05	0.00035	CcSEcCtD
Lisuride—Constipation—Trandolapril—hypertension	3.73e-05	0.000349	CcSEcCtD
Lisuride—Asthenia—Doxazosin—hypertension	3.72e-05	0.000349	CcSEcCtD
Lisuride—Decreased appetite—Telmisartan—hypertension	3.72e-05	0.000349	CcSEcCtD
Lisuride—Nervous system disorder—Losartan—hypertension	3.72e-05	0.000348	CcSEcCtD
Lisuride—Constipation—Enalapril—hypertension	3.71e-05	0.000348	CcSEcCtD
Lisuride—Dyspnoea—Captopril—hypertension	3.71e-05	0.000348	CcSEcCtD
Lisuride—Anorexia—Betaxolol—hypertension	3.71e-05	0.000347	CcSEcCtD
Lisuride—Somnolence—Captopril—hypertension	3.7e-05	0.000347	CcSEcCtD
Lisuride—Tachycardia—Losartan—hypertension	3.7e-05	0.000347	CcSEcCtD
Lisuride—Gastrointestinal disorder—Telmisartan—hypertension	3.7e-05	0.000346	CcSEcCtD
Lisuride—Fatigue—Telmisartan—hypertension	3.69e-05	0.000346	CcSEcCtD
Lisuride—Feeling abnormal—Clonidine—hypertension	3.68e-05	0.000345	CcSEcCtD
Lisuride—Asthenia—Fosinopril—hypertension	3.68e-05	0.000344	CcSEcCtD
Lisuride—Hyperhidrosis—Losartan—hypertension	3.66e-05	0.000343	CcSEcCtD
Lisuride—Constipation—Telmisartan—hypertension	3.66e-05	0.000343	CcSEcCtD
Lisuride—Insomnia—Perindopril—hypertension	3.66e-05	0.000342	CcSEcCtD
Lisuride—Asthenia—Eplerenone—hypertension	3.65e-05	0.000342	CcSEcCtD
Lisuride—Ergotamine—HTR2A—hypertension	3.65e-05	0.0104	CrCbGaD
Lisuride—Mental disorder—Lisinopril—hypertension	3.63e-05	0.000341	CcSEcCtD
Lisuride—Asthenia—Nifedipine—hypertension	3.63e-05	0.00034	CcSEcCtD
Lisuride—Dizziness—Propranolol—hypertension	3.62e-05	0.000339	CcSEcCtD
Lisuride—Decreased appetite—Captopril—hypertension	3.62e-05	0.000339	CcSEcCtD
Lisuride—Anorexia—Losartan—hypertension	3.61e-05	0.000339	CcSEcCtD
Lisuride—Insomnia—Hydrochlorothiazide—hypertension	3.61e-05	0.000339	CcSEcCtD
Lisuride—Asthenia—Verapamil—hypertension	3.61e-05	0.000338	CcSEcCtD
Lisuride—Malnutrition—Lisinopril—hypertension	3.61e-05	0.000338	CcSEcCtD
Lisuride—Dyspnoea—Perindopril—hypertension	3.6e-05	0.000338	CcSEcCtD
Lisuride—Somnolence—Perindopril—hypertension	3.59e-05	0.000337	CcSEcCtD
Lisuride—Dyspnoea—Irbesartan—hypertension	3.59e-05	0.000336	CcSEcCtD
Lisuride—Feeling abnormal—Trandolapril—hypertension	3.59e-05	0.000336	CcSEcCtD
Lisuride—Fatigue—Captopril—hypertension	3.59e-05	0.000336	CcSEcCtD
Lisuride—Somnolence—Irbesartan—hypertension	3.58e-05	0.000335	CcSEcCtD
Lisuride—Vertigo—Ramipril—hypertension	3.58e-05	0.000335	CcSEcCtD
Lisuride—Feeling abnormal—Enalapril—hypertension	3.58e-05	0.000335	CcSEcCtD
Lisuride—Syncope—Ramipril—hypertension	3.57e-05	0.000335	CcSEcCtD
Lisuride—Dyspnoea—Hydrochlorothiazide—hypertension	3.56e-05	0.000334	CcSEcCtD
Lisuride—Constipation—Captopril—hypertension	3.56e-05	0.000333	CcSEcCtD
Lisuride—Somnolence—Hydrochlorothiazide—hypertension	3.55e-05	0.000333	CcSEcCtD
Lisuride—Feeling abnormal—Telmisartan—hypertension	3.53e-05	0.00033	CcSEcCtD
Lisuride—Palpitations—Ramipril—hypertension	3.52e-05	0.00033	CcSEcCtD
Lisuride—Insomnia—Betaxolol—hypertension	3.52e-05	0.00033	CcSEcCtD
Lisuride—Decreased appetite—Perindopril—hypertension	3.51e-05	0.000329	CcSEcCtD
Lisuride—Dizziness—Indapamide—hypertension	3.5e-05	0.000328	CcSEcCtD
Lisuride—Dizziness—Diltiazem—hypertension	3.5e-05	0.000328	CcSEcCtD
Lisuride—Decreased appetite—Irbesartan—hypertension	3.5e-05	0.000328	CcSEcCtD
Lisuride—Vertigo—Timolol—hypertension	3.5e-05	0.000328	CcSEcCtD
Lisuride—Somnolence—Furosemide—hypertension	3.49e-05	0.000327	CcSEcCtD
Lisuride—Syncope—Timolol—hypertension	3.49e-05	0.000327	CcSEcCtD
Lisuride—Gastrointestinal disorder—Perindopril—hypertension	3.49e-05	0.000327	CcSEcCtD
Lisuride—Fatigue—Perindopril—hypertension	3.48e-05	0.000326	CcSEcCtD
Lisuride—Vomiting—Propranolol—hypertension	3.48e-05	0.000326	CcSEcCtD
Lisuride—Gastrointestinal disorder—Irbesartan—hypertension	3.48e-05	0.000326	CcSEcCtD
Lisuride—Cough—Ramipril—hypertension	3.48e-05	0.000326	CcSEcCtD
Lisuride—Decreased appetite—Hydrochlorothiazide—hypertension	3.47e-05	0.000325	CcSEcCtD
Lisuride—Fatigue—Irbesartan—hypertension	3.47e-05	0.000325	CcSEcCtD
Lisuride—Dizziness—Carvedilol—hypertension	3.47e-05	0.000325	CcSEcCtD
Lisuride—Dyspnoea—Betaxolol—hypertension	3.47e-05	0.000325	CcSEcCtD
Lisuride—Constipation—Perindopril—hypertension	3.46e-05	0.000324	CcSEcCtD
Lisuride—Constipation—Irbesartan—hypertension	3.44e-05	0.000323	CcSEcCtD
Lisuride—Fatigue—Hydrochlorothiazide—hypertension	3.44e-05	0.000323	CcSEcCtD
Lisuride—Palpitations—Timolol—hypertension	3.44e-05	0.000322	CcSEcCtD
Lisuride—Dizziness—Doxazosin—hypertension	3.43e-05	0.000321	CcSEcCtD
Lisuride—Feeling abnormal—Captopril—hypertension	3.43e-05	0.000321	CcSEcCtD
Lisuride—Insomnia—Losartan—hypertension	3.43e-05	0.000321	CcSEcCtD
Lisuride—Constipation—Hydrochlorothiazide—hypertension	3.42e-05	0.00032	CcSEcCtD
Lisuride—Decreased appetite—Furosemide—hypertension	3.42e-05	0.00032	CcSEcCtD
Lisuride—Cough—Timolol—hypertension	3.4e-05	0.000318	CcSEcCtD
Lisuride—Gastrointestinal disorder—Furosemide—hypertension	3.39e-05	0.000318	CcSEcCtD
Lisuride—Dizziness—Fosinopril—hypertension	3.39e-05	0.000317	CcSEcCtD
Lisuride—Fatigue—Furosemide—hypertension	3.39e-05	0.000317	CcSEcCtD
Lisuride—Decreased appetite—Betaxolol—hypertension	3.38e-05	0.000317	CcSEcCtD
Lisuride—Dyspnoea—Losartan—hypertension	3.38e-05	0.000317	CcSEcCtD
Lisuride—Anxiety—Ramipril—hypertension	3.38e-05	0.000317	CcSEcCtD
Lisuride—Somnolence—Losartan—hypertension	3.37e-05	0.000316	CcSEcCtD
Lisuride—Dizziness—Eplerenone—hypertension	3.37e-05	0.000316	CcSEcCtD
Lisuride—Vomiting—Indapamide—hypertension	3.37e-05	0.000316	CcSEcCtD
Lisuride—Vomiting—Diltiazem—hypertension	3.37e-05	0.000316	CcSEcCtD
Lisuride—Asthenia—Valsartan—hypertension	3.36e-05	0.000315	CcSEcCtD
Lisuride—Constipation—Furosemide—hypertension	3.36e-05	0.000315	CcSEcCtD
Lisuride—Gastrointestinal disorder—Betaxolol—hypertension	3.36e-05	0.000315	CcSEcCtD
Lisuride—Fatigue—Betaxolol—hypertension	3.35e-05	0.000314	CcSEcCtD
Lisuride—Asthenia—Olmesartan—hypertension	3.35e-05	0.000314	CcSEcCtD
Lisuride—Dizziness—Nifedipine—hypertension	3.34e-05	0.000313	CcSEcCtD
Lisuride—Vomiting—Carvedilol—hypertension	3.34e-05	0.000312	CcSEcCtD
Lisuride—Feeling abnormal—Perindopril—hypertension	3.33e-05	0.000312	CcSEcCtD
Lisuride—Dizziness—Verapamil—hypertension	3.33e-05	0.000312	CcSEcCtD
Lisuride—Constipation—Betaxolol—hypertension	3.33e-05	0.000312	CcSEcCtD
Lisuride—Feeling abnormal—Irbesartan—hypertension	3.32e-05	0.000311	CcSEcCtD
Lisuride—Headache—Diltiazem—hypertension	3.32e-05	0.000311	CcSEcCtD
Lisuride—Headache—Indapamide—hypertension	3.32e-05	0.000311	CcSEcCtD
Lisuride—Dry mouth—Ramipril—hypertension	3.32e-05	0.000311	CcSEcCtD
Lisuride—Anxiety—Timolol—hypertension	3.3e-05	0.000309	CcSEcCtD
Lisuride—Vomiting—Doxazosin—hypertension	3.3e-05	0.000309	CcSEcCtD
Lisuride—Decreased appetite—Losartan—hypertension	3.3e-05	0.000309	CcSEcCtD
Lisuride—Feeling abnormal—Hydrochlorothiazide—hypertension	3.29e-05	0.000308	CcSEcCtD
Lisuride—Headache—Carvedilol—hypertension	3.29e-05	0.000308	CcSEcCtD
Lisuride—Confusional state—Ramipril—hypertension	3.28e-05	0.000307	CcSEcCtD
Lisuride—Fatigue—Losartan—hypertension	3.27e-05	0.000306	CcSEcCtD
Lisuride—Vomiting—Fosinopril—hypertension	3.26e-05	0.000305	CcSEcCtD
Lisuride—Headache—Doxazosin—hypertension	3.25e-05	0.000304	CcSEcCtD
Lisuride—Vertigo—Lisinopril—hypertension	3.24e-05	0.000304	CcSEcCtD
Lisuride—Dry mouth—Timolol—hypertension	3.24e-05	0.000304	CcSEcCtD
Lisuride—Constipation—Losartan—hypertension	3.24e-05	0.000304	CcSEcCtD
Lisuride—Syncope—Lisinopril—hypertension	3.24e-05	0.000303	CcSEcCtD
Lisuride—Vomiting—Eplerenone—hypertension	3.24e-05	0.000303	CcSEcCtD
Lisuride—Feeling abnormal—Furosemide—hypertension	3.24e-05	0.000303	CcSEcCtD
Lisuride—Vomiting—Nifedipine—hypertension	3.21e-05	0.000301	CcSEcCtD
Lisuride—Headache—Fosinopril—hypertension	3.21e-05	0.000301	CcSEcCtD
Lisuride—Asthenia—Clonidine—hypertension	3.21e-05	0.0003	CcSEcCtD
Lisuride—Feeling abnormal—Betaxolol—hypertension	3.21e-05	0.0003	CcSEcCtD
Lisuride—Confusional state—Timolol—hypertension	3.2e-05	0.0003	CcSEcCtD
Lisuride—Vomiting—Verapamil—hypertension	3.2e-05	0.0003	CcSEcCtD
Lisuride—Palpitations—Lisinopril—hypertension	3.19e-05	0.000299	CcSEcCtD
Lisuride—Headache—Eplerenone—hypertension	3.19e-05	0.000299	CcSEcCtD
Lisuride—Nervous system disorder—Ramipril—hypertension	3.19e-05	0.000299	CcSEcCtD
Lisuride—Tachycardia—Ramipril—hypertension	3.17e-05	0.000297	CcSEcCtD
Lisuride—Headache—Nifedipine—hypertension	3.17e-05	0.000297	CcSEcCtD
Lisuride—Infection—Timolol—hypertension	3.16e-05	0.000296	CcSEcCtD
Lisuride—Headache—Verapamil—hypertension	3.15e-05	0.000295	CcSEcCtD
Lisuride—Cough—Lisinopril—hypertension	3.15e-05	0.000295	CcSEcCtD
Lisuride—Hyperhidrosis—Ramipril—hypertension	3.14e-05	0.000294	CcSEcCtD
Lisuride—Asthenia—Trandolapril—hypertension	3.13e-05	0.000293	CcSEcCtD
Lisuride—Feeling abnormal—Losartan—hypertension	3.12e-05	0.000293	CcSEcCtD
Lisuride—Nervous system disorder—Timolol—hypertension	3.12e-05	0.000292	CcSEcCtD
Lisuride—Asthenia—Enalapril—hypertension	3.11e-05	0.000292	CcSEcCtD
Lisuride—Dizziness—Valsartan—hypertension	3.1e-05	0.00029	CcSEcCtD
Lisuride—Anorexia—Ramipril—hypertension	3.1e-05	0.00029	CcSEcCtD
Lisuride—Dizziness—Olmesartan—hypertension	3.08e-05	0.000289	CcSEcCtD
Lisuride—Hyperhidrosis—Timolol—hypertension	3.07e-05	0.000288	CcSEcCtD
Lisuride—Asthenia—Telmisartan—hypertension	3.07e-05	0.000288	CcSEcCtD
Lisuride—Anxiety—Lisinopril—hypertension	3.06e-05	0.000287	CcSEcCtD
Lisuride—Anorexia—Timolol—hypertension	3.03e-05	0.000284	CcSEcCtD
Lisuride—Dry mouth—Lisinopril—hypertension	3.01e-05	0.000282	CcSEcCtD
Lisuride—Asthenia—Captopril—hypertension	2.99e-05	0.00028	CcSEcCtD
Lisuride—Vomiting—Valsartan—hypertension	2.98e-05	0.000279	CcSEcCtD
Lisuride—Confusional state—Lisinopril—hypertension	2.97e-05	0.000278	CcSEcCtD
Lisuride—Vomiting—Olmesartan—hypertension	2.97e-05	0.000278	CcSEcCtD
Lisuride—Dizziness—Clonidine—hypertension	2.95e-05	0.000277	CcSEcCtD
Lisuride—Insomnia—Ramipril—hypertension	2.94e-05	0.000275	CcSEcCtD
Lisuride—Headache—Valsartan—hypertension	2.94e-05	0.000275	CcSEcCtD
Lisuride—Infection—Lisinopril—hypertension	2.93e-05	0.000274	CcSEcCtD
Lisuride—Headache—Olmesartan—hypertension	2.92e-05	0.000274	CcSEcCtD
Lisuride—Asthenia—Perindopril—hypertension	2.9e-05	0.000272	CcSEcCtD
Lisuride—Dyspnoea—Ramipril—hypertension	2.9e-05	0.000271	CcSEcCtD
Lisuride—Asthenia—Irbesartan—hypertension	2.89e-05	0.000271	CcSEcCtD
Lisuride—Somnolence—Ramipril—hypertension	2.89e-05	0.000271	CcSEcCtD
Lisuride—Dizziness—Trandolapril—hypertension	2.88e-05	0.00027	CcSEcCtD
Lisuride—Tachycardia—Lisinopril—hypertension	2.88e-05	0.00027	CcSEcCtD
Lisuride—Insomnia—Timolol—hypertension	2.87e-05	0.000269	CcSEcCtD
Lisuride—Dizziness—Enalapril—hypertension	2.87e-05	0.000269	CcSEcCtD
Lisuride—Asthenia—Hydrochlorothiazide—hypertension	2.87e-05	0.000269	CcSEcCtD
Lisuride—Hyperhidrosis—Lisinopril—hypertension	2.85e-05	0.000267	CcSEcCtD
Lisuride—Vomiting—Clonidine—hypertension	2.84e-05	0.000266	CcSEcCtD
Lisuride—Dyspnoea—Timolol—hypertension	2.83e-05	0.000265	CcSEcCtD
Lisuride—Dizziness—Telmisartan—hypertension	2.83e-05	0.000265	CcSEcCtD
Lisuride—Decreased appetite—Ramipril—hypertension	2.83e-05	0.000265	CcSEcCtD
Lisuride—Somnolence—Timolol—hypertension	2.82e-05	0.000265	CcSEcCtD
Lisuride—Asthenia—Furosemide—hypertension	2.82e-05	0.000264	CcSEcCtD
Lisuride—Anorexia—Lisinopril—hypertension	2.81e-05	0.000263	CcSEcCtD
Lisuride—Gastrointestinal disorder—Ramipril—hypertension	2.81e-05	0.000263	CcSEcCtD
Lisuride—Fatigue—Ramipril—hypertension	2.8e-05	0.000263	CcSEcCtD
Lisuride—Headache—Clonidine—hypertension	2.8e-05	0.000262	CcSEcCtD
Lisuride—Asthenia—Betaxolol—hypertension	2.79e-05	0.000261	CcSEcCtD
Lisuride—Constipation—Ramipril—hypertension	2.78e-05	0.00026	CcSEcCtD
Lisuride—Vomiting—Trandolapril—hypertension	2.77e-05	0.00026	CcSEcCtD
Lisuride—Decreased appetite—Timolol—hypertension	2.76e-05	0.000259	CcSEcCtD
Lisuride—Vomiting—Enalapril—hypertension	2.76e-05	0.000259	CcSEcCtD
Lisuride—Dizziness—Captopril—hypertension	2.75e-05	0.000258	CcSEcCtD
Lisuride—Gastrointestinal disorder—Timolol—hypertension	2.74e-05	0.000257	CcSEcCtD
Lisuride—Fatigue—Timolol—hypertension	2.74e-05	0.000257	CcSEcCtD
Lisuride—Headache—Trandolapril—hypertension	2.73e-05	0.000256	CcSEcCtD
Lisuride—Vomiting—Telmisartan—hypertension	2.72e-05	0.000255	CcSEcCtD
Lisuride—Asthenia—Losartan—hypertension	2.72e-05	0.000255	CcSEcCtD
Lisuride—Headache—Enalapril—hypertension	2.72e-05	0.000255	CcSEcCtD
Lisuride—Headache—Telmisartan—hypertension	2.68e-05	0.000251	CcSEcCtD
Lisuride—Feeling abnormal—Ramipril—hypertension	2.68e-05	0.000251	CcSEcCtD
Lisuride—Dizziness—Perindopril—hypertension	2.67e-05	0.00025	CcSEcCtD
Lisuride—Insomnia—Lisinopril—hypertension	2.67e-05	0.00025	CcSEcCtD
Lisuride—Dizziness—Irbesartan—hypertension	2.66e-05	0.00025	CcSEcCtD
Lisuride—Vomiting—Captopril—hypertension	2.65e-05	0.000248	CcSEcCtD
Lisuride—Dizziness—Hydrochlorothiazide—hypertension	2.64e-05	0.000248	CcSEcCtD
Lisuride—Dyspnoea—Lisinopril—hypertension	2.63e-05	0.000246	CcSEcCtD
Lisuride—Somnolence—Lisinopril—hypertension	2.62e-05	0.000246	CcSEcCtD
Lisuride—Feeling abnormal—Timolol—hypertension	2.62e-05	0.000245	CcSEcCtD
Lisuride—Headache—Captopril—hypertension	2.61e-05	0.000244	CcSEcCtD
Lisuride—Dizziness—Furosemide—hypertension	2.6e-05	0.000243	CcSEcCtD
Lisuride—Dizziness—Betaxolol—hypertension	2.57e-05	0.000241	CcSEcCtD
Lisuride—Vomiting—Perindopril—hypertension	2.57e-05	0.000241	CcSEcCtD
Lisuride—Decreased appetite—Lisinopril—hypertension	2.56e-05	0.00024	CcSEcCtD
Lisuride—Vomiting—Irbesartan—hypertension	2.56e-05	0.00024	CcSEcCtD
Lisuride—Gastrointestinal disorder—Lisinopril—hypertension	2.54e-05	0.000238	CcSEcCtD
Lisuride—Fatigue—Lisinopril—hypertension	2.54e-05	0.000238	CcSEcCtD
Lisuride—Vomiting—Hydrochlorothiazide—hypertension	2.54e-05	0.000238	CcSEcCtD
Lisuride—Headache—Perindopril—hypertension	2.53e-05	0.000237	CcSEcCtD
Lisuride—Headache—Irbesartan—hypertension	2.52e-05	0.000236	CcSEcCtD
Lisuride—Constipation—Lisinopril—hypertension	2.52e-05	0.000236	CcSEcCtD
Lisuride—Dizziness—Losartan—hypertension	2.51e-05	0.000235	CcSEcCtD
Lisuride—Headache—Hydrochlorothiazide—hypertension	2.5e-05	0.000234	CcSEcCtD
Lisuride—Vomiting—Furosemide—hypertension	2.5e-05	0.000234	CcSEcCtD
Lisuride—Vomiting—Betaxolol—hypertension	2.47e-05	0.000232	CcSEcCtD
Lisuride—Headache—Furosemide—hypertension	2.46e-05	0.000231	CcSEcCtD
Lisuride—Headache—Betaxolol—hypertension	2.44e-05	0.000228	CcSEcCtD
Lisuride—Feeling abnormal—Lisinopril—hypertension	2.43e-05	0.000228	CcSEcCtD
Lisuride—Vomiting—Losartan—hypertension	2.41e-05	0.000226	CcSEcCtD
Lisuride—Headache—Losartan—hypertension	2.37e-05	0.000222	CcSEcCtD
Lisuride—Asthenia—Ramipril—hypertension	2.33e-05	0.000218	CcSEcCtD
Lisuride—Asthenia—Timolol—hypertension	2.28e-05	0.000214	CcSEcCtD
Lisuride—Dizziness—Ramipril—hypertension	2.15e-05	0.000201	CcSEcCtD
Lisuride—Asthenia—Lisinopril—hypertension	2.11e-05	0.000198	CcSEcCtD
Lisuride—Dizziness—Timolol—hypertension	2.1e-05	0.000197	CcSEcCtD
Lisuride—Vomiting—Ramipril—hypertension	2.07e-05	0.000194	CcSEcCtD
Lisuride—Headache—Ramipril—hypertension	2.04e-05	0.000191	CcSEcCtD
Lisuride—Vomiting—Timolol—hypertension	2.02e-05	0.000189	CcSEcCtD
Lisuride—Headache—Timolol—hypertension	1.99e-05	0.000186	CcSEcCtD
Lisuride—Dizziness—Lisinopril—hypertension	1.95e-05	0.000183	CcSEcCtD
Lisuride—Vomiting—Lisinopril—hypertension	1.87e-05	0.000176	CcSEcCtD
Lisuride—Headache—Lisinopril—hypertension	1.85e-05	0.000173	CcSEcCtD
Lisuride—DRD3—Signaling Pathways—SRC—hypertension	5.25e-07	5.63e-06	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—SRC—hypertension	5.25e-07	5.63e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CXCL8—hypertension	5.22e-07	5.61e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—IL6—hypertension	5.21e-07	5.6e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—IL6—hypertension	5.19e-07	5.57e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—MMP9—hypertension	5.18e-07	5.57e-06	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—VEGFA—hypertension	5.18e-07	5.56e-06	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—EGFR—hypertension	5.18e-07	5.56e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CDKN1A—hypertension	5.17e-07	5.55e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—TH—hypertension	5.16e-07	5.55e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—AGT—hypertension	5.16e-07	5.54e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—PTEN—hypertension	5.15e-07	5.54e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CALM2—hypertension	5.14e-07	5.53e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—MMP9—hypertension	5.14e-07	5.52e-06	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—AKT1—hypertension	5.12e-07	5.5e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CDKN1A—hypertension	5.12e-07	5.5e-06	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—VEGFA—hypertension	5.11e-07	5.49e-06	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—VEGFA—hypertension	5.11e-07	5.49e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—RELA—hypertension	5.11e-07	5.49e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—PTEN—hypertension	5.11e-07	5.49e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—SERPINE1—hypertension	5.09e-07	5.46e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CALM1—hypertension	5.07e-07	5.45e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—APOE—hypertension	5.05e-07	5.43e-06	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—MYC—hypertension	5.05e-07	5.43e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—IL6—hypertension	5.04e-07	5.42e-06	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—AKT1—hypertension	5.04e-07	5.42e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—MAPK8—hypertension	5.04e-07	5.42e-06	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TGFB1—hypertension	5.04e-07	5.41e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—AKT1—hypertension	5.03e-07	5.4e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—RELA—hypertension	5.03e-07	5.4e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—SLC2A4—hypertension	5.02e-07	5.39e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GCG—hypertension	5.02e-07	5.39e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MTOR—hypertension	5.01e-07	5.38e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CAV1—hypertension	5.01e-07	5.38e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—MAPK8—hypertension	5e-07	5.37e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—APOA1—hypertension	4.99e-07	5.37e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—AKT1—hypertension	4.98e-07	5.35e-06	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—AKT1—hypertension	4.97e-07	5.34e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—IL6—hypertension	4.96e-07	5.33e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—MMP9—hypertension	4.96e-07	5.33e-06	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—EGFR—hypertension	4.94e-07	5.31e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CDKN1A—hypertension	4.94e-07	5.31e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—MMP9—hypertension	4.93e-07	5.3e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—PTEN—hypertension	4.93e-07	5.29e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MTOR—hypertension	4.93e-07	5.29e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—FGF2—hypertension	4.93e-07	5.29e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CDKN1A—hypertension	4.92e-07	5.28e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—EP300—hypertension	4.91e-07	5.28e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—RHOA—hypertension	4.91e-07	5.27e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—PTEN—hypertension	4.9e-07	5.27e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—EP300—hypertension	4.87e-07	5.23e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GOT1—hypertension	4.86e-07	5.22e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—NOS3—hypertension	4.86e-07	5.22e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—PIK3R1—hypertension	4.86e-07	5.22e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—MAPK8—hypertension	4.82e-07	5.18e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CXCL8—hypertension	4.81e-07	5.17e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—AKT1—hypertension	4.81e-07	5.17e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—MMP9—hypertension	4.8e-07	5.15e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—MAPK8—hypertension	4.8e-07	5.15e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—AKT1—hypertension	4.78e-07	5.14e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CDKN1A—hypertension	4.78e-07	5.14e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—SRC—hypertension	4.78e-07	5.13e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—PTEN—hypertension	4.77e-07	5.12e-06	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—MYC—hypertension	4.76e-07	5.12e-06	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TGFB1—hypertension	4.75e-07	5.1e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CXCL8—hypertension	4.74e-07	5.09e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—SRC—hypertension	4.74e-07	5.09e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—MMP9—hypertension	4.72e-07	5.07e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—STK11—hypertension	4.72e-07	5.07e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CYP19A1—hypertension	4.72e-07	5.07e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CDKN1A—hypertension	4.7e-07	5.05e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—EP300—hypertension	4.7e-07	5.05e-06	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—MYC—hypertension	4.7e-07	5.05e-06	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—MYC—hypertension	4.7e-07	5.05e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—PTEN—hypertension	4.69e-07	5.04e-06	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TGFB1—hypertension	4.69e-07	5.04e-06	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TGFB1—hypertension	4.69e-07	5.04e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—EP300—hypertension	4.68e-07	5.02e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—MAPK8—hypertension	4.67e-07	5.01e-06	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—EGFR—hypertension	4.66e-07	5e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—VEGFA—hypertension	4.65e-07	5e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—AKT1—hypertension	4.65e-07	5e-06	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—AKT1—hypertension	4.65e-07	4.99e-06	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PTEN—hypertension	4.63e-07	4.98e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—VEGFA—hypertension	4.61e-07	4.95e-06	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—EGFR—hypertension	4.6e-07	4.94e-06	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—EGFR—hypertension	4.6e-07	4.94e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—MAPK8—hypertension	4.59e-07	4.93e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—AKT1—hypertension	4.58e-07	4.92e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—IL6—hypertension	4.58e-07	4.92e-06	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—AKT1—hypertension	4.57e-07	4.91e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—RELA—hypertension	4.57e-07	4.91e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—SRC—hypertension	4.57e-07	4.91e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—EP300—hypertension	4.55e-07	4.89e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—SRC—hypertension	4.55e-07	4.89e-06	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TP53—hypertension	4.51e-07	4.84e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—IL6—hypertension	4.5e-07	4.84e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MTOR—hypertension	4.48e-07	4.82e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—EP300—hypertension	4.48e-07	4.81e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—VEGFA—hypertension	4.45e-07	4.78e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—VEGFA—hypertension	4.43e-07	4.76e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—SRC—hypertension	4.42e-07	4.75e-06	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—EP300—hypertension	4.42e-07	4.75e-06	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TP53—hypertension	4.42e-07	4.74e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PPARG—hypertension	4.4e-07	4.73e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—COMT—hypertension	4.39e-07	4.72e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—SRC—hypertension	4.35e-07	4.68e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MMP9—hypertension	4.35e-07	4.68e-06	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TP53—hypertension	4.35e-07	4.67e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—POMC—hypertension	4.34e-07	4.66e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CDKN1A—hypertension	4.34e-07	4.66e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GNB3—hypertension	4.33e-07	4.65e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PPARGC1A—hypertension	4.33e-07	4.65e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—PTEN—hypertension	4.33e-07	4.65e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—INS—hypertension	4.32e-07	4.64e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—HMOX1—hypertension	4.31e-07	4.63e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CXCL8—hypertension	4.31e-07	4.63e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—VEGFA—hypertension	4.31e-07	4.63e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MMP9—hypertension	4.28e-07	4.6e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—MYC—hypertension	4.28e-07	4.6e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TGFB1—hypertension	4.27e-07	4.59e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CDKN1A—hypertension	4.27e-07	4.58e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—PTEN—hypertension	4.26e-07	4.57e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CAT—hypertension	4.25e-07	4.57e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—MYC—hypertension	4.24e-07	4.56e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—VEGFA—hypertension	4.24e-07	4.55e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MAPK8—hypertension	4.23e-07	4.55e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TGFB1—hypertension	4.23e-07	4.55e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—AKT1—hypertension	4.22e-07	4.54e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GNAS—hypertension	4.21e-07	4.53e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—EGFR—hypertension	4.19e-07	4.5e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MAPK8—hypertension	4.17e-07	4.47e-06	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—AKT1—hypertension	4.16e-07	4.47e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—AKT1—hypertension	4.15e-07	4.46e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—EGFR—hypertension	4.15e-07	4.46e-06	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TP53—hypertension	4.15e-07	4.46e-06	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL6—hypertension	4.13e-07	4.43e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—EP300—hypertension	4.13e-07	4.43e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—APOB—hypertension	4.13e-07	4.43e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL6—hypertension	4.1e-07	4.4e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—MYC—hypertension	4.1e-07	4.4e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TGFB1—hypertension	4.09e-07	4.39e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—MYC—hypertension	4.08e-07	4.38e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TGFB1—hypertension	4.07e-07	4.37e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—EP300—hypertension	4.06e-07	4.36e-06	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL6—hypertension	4.04e-07	4.34e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GSTM1—hypertension	4.01e-07	4.31e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—SRC—hypertension	4.01e-07	4.31e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—EGFR—hypertension	4.01e-07	4.3e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—EGFR—hypertension	3.99e-07	4.28e-06	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL6—hypertension	3.98e-07	4.27e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—MYC—hypertension	3.96e-07	4.26e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—ALB—hypertension	3.96e-07	4.25e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TGFB1—hypertension	3.95e-07	4.25e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—SRC—hypertension	3.95e-07	4.24e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—LPL—hypertension	3.94e-07	4.23e-06	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TP53—hypertension	3.91e-07	4.2e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—VEGFA—hypertension	3.91e-07	4.2e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—MYC—hypertension	3.9e-07	4.19e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MMP9—hypertension	3.9e-07	4.19e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TGFB1—hypertension	3.89e-07	4.18e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CDKN1A—hypertension	3.88e-07	4.17e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—EGFR—hypertension	3.88e-07	4.16e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—PTEN—hypertension	3.87e-07	4.16e-06	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TP53—hypertension	3.86e-07	4.15e-06	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TP53—hypertension	3.86e-07	4.15e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ADCY5—hypertension	3.86e-07	4.14e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—VEGFA—hypertension	3.85e-07	4.13e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GPX1—hypertension	3.84e-07	4.13e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—EGFR—hypertension	3.82e-07	4.1e-06	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—AKT1—hypertension	3.81e-07	4.09e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CYP1A1—hypertension	3.81e-07	4.09e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PRKCA—hypertension	3.81e-07	4.09e-06	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL6—hypertension	3.8e-07	4.08e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MAPK8—hypertension	3.79e-07	4.07e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—NOS3—hypertension	3.79e-07	4.07e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PIK3R1—hypertension	3.79e-07	4.07e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—AKT1—hypertension	3.78e-07	4.06e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CD36—hypertension	3.74e-07	4.02e-06	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—AKT1—hypertension	3.73e-07	4.01e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—EP300—hypertension	3.69e-07	3.97e-06	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—AKT1—hypertension	3.67e-07	3.94e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MYC—hypertension	3.6e-07	3.86e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—SRC—hypertension	3.59e-07	3.86e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TGFB1—hypertension	3.59e-07	3.85e-06	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL6—hypertension	3.58e-07	3.85e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—MTHFR—hypertension	3.55e-07	3.81e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MYC—hypertension	3.54e-07	3.8e-06	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL6—hypertension	3.53e-07	3.8e-06	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL6—hypertension	3.53e-07	3.8e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TGFB1—hypertension	3.53e-07	3.79e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—EGFR—hypertension	3.52e-07	3.78e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TP53—hypertension	3.52e-07	3.78e-06	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—AKT1—hypertension	3.5e-07	3.76e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—VEGFA—hypertension	3.5e-07	3.76e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TP53—hypertension	3.48e-07	3.74e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PPARA—hypertension	3.48e-07	3.74e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PTGS2—hypertension	3.46e-07	3.72e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—EGFR—hypertension	3.46e-07	3.72e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—AGT—hypertension	3.37e-07	3.62e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TP53—hypertension	3.36e-07	3.61e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TP53—hypertension	3.35e-07	3.6e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CALM1—hypertension	3.32e-07	3.56e-06	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—AKT1—hypertension	3.3e-07	3.55e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—APOE—hypertension	3.3e-07	3.55e-06	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—AKT1—hypertension	3.29e-07	3.53e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CAV1—hypertension	3.27e-07	3.52e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—APOA1—hypertension	3.27e-07	3.51e-06	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—AKT1—hypertension	3.26e-07	3.5e-06	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—AKT1—hypertension	3.26e-07	3.5e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TP53—hypertension	3.26e-07	3.5e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MYC—hypertension	3.22e-07	3.46e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL6—hypertension	3.22e-07	3.46e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TGFB1—hypertension	3.21e-07	3.45e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TP53—hypertension	3.2e-07	3.44e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL6—hypertension	3.19e-07	3.43e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—EGFR—hypertension	3.15e-07	3.38e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL6—hypertension	3.08e-07	3.31e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL6—hypertension	3.06e-07	3.29e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PTEN—hypertension	3.02e-07	3.24e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL6—hypertension	2.98e-07	3.2e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—AKT1—hypertension	2.97e-07	3.19e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TP53—hypertension	2.95e-07	3.17e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—AKT1—hypertension	2.94e-07	3.16e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL6—hypertension	2.93e-07	3.15e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TP53—hypertension	2.91e-07	3.12e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—EP300—hypertension	2.88e-07	3.09e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PPARG—hypertension	2.88e-07	3.09e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—AKT1—hypertension	2.84e-07	3.05e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—POMC—hypertension	2.84e-07	3.05e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—AKT1—hypertension	2.83e-07	3.04e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—INS—hypertension	2.82e-07	3.03e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—AKT1—hypertension	2.75e-07	2.95e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—AKT1—hypertension	2.71e-07	2.91e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL6—hypertension	2.7e-07	2.9e-06	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—AKT1—hypertension	2.67e-07	2.87e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL6—hypertension	2.66e-07	2.86e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TP53—hypertension	2.64e-07	2.84e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ALB—hypertension	2.59e-07	2.78e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—AKT1—hypertension	2.49e-07	2.68e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PIK3R1—hypertension	2.47e-07	2.66e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—NOS3—hypertension	2.47e-07	2.66e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—AKT1—hypertension	2.45e-07	2.64e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL6—hypertension	2.42e-07	2.6e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PTGS2—hypertension	2.26e-07	2.43e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—AKT1—hypertension	2.23e-07	2.4e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PTEN—hypertension	1.97e-07	2.12e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—EP300—hypertension	1.88e-07	2.02e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—AKT1—hypertension	1.74e-07	1.87e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—AKT1—hypertension	1.14e-07	1.22e-06	CbGpPWpGaD
